Anticipating Results from Semaglutide Treatment Begin your semaglutide treatment with an initial low dose, gradually elevated to suit your tolerance and weight loss progress
Continued research led to the first GLP-1 drugs approved for weight loss in people with obesity or overweight: liraglutide or Saxenda in 2014, semaglutide as Wagovy in 2021 and tirzepatide as Zepbound in 2023
For example, someone using semaglutide should also follow a heart-healthy diet, exercise regularly, lose excess weight, quit smoking, and take any additional medications prescribed by their doctor
What is tirzepatide
Moreover, a peripherally administered GLP-1R antagonist increased alcohol consumption while GLP-1R activation in the VTA was sufficient to reduce alcohol consumption in rats, indicating that the effect may be mediated by GLP-1R in the VTA (Shirazi et al., 2013)